000294812 001__ 294812
000294812 005__ 20241204182818.0
000294812 0247_ $$2doi$$a10.1007/s00520-024-09049-2
000294812 0247_ $$2pmid$$apmid:39623080
000294812 0247_ $$2pmc$$apmc:PMC11611996
000294812 0247_ $$2ISSN$$a0941-4355
000294812 0247_ $$2ISSN$$a1433-7339
000294812 037__ $$aDKFZ-2024-02524
000294812 041__ $$aEnglish
000294812 082__ $$a610
000294812 1001_ $$0P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994$$aZhu, Chunsu$$b0$$eFirst author$$udkfz
000294812 245__ $$aCombined lifestyle factors on mortality and cardiovascular disease among cancer survivors: a systematic review and meta-analysis of cohort studies.
000294812 260__ $$aNew York,NY$$bSpringer$$c2024
000294812 3367_ $$2DRIVER$$aarticle
000294812 3367_ $$2DataCite$$aOutput Types/Journal article
000294812 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1733320108_20390$$xReview Article
000294812 3367_ $$2BibTeX$$aARTICLE
000294812 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294812 3367_ $$00$$2EndNote$$aJournal Article
000294812 500__ $$a#EA:C071#LA:C071#
000294812 520__ $$aLifestyle factors in cancer survivors are frequently studied individually even though they are often interconnected. This systematic review and meta-analysis investigated the association of combined lifestyle factors on health outcomes among cancer survivors.EMBASE, PubMed and Web of Science were searched up to March 2024. Cohort studies examining the associations of at least three combined lifestyle factors with mortality (all-cause/cancer-specific) and cardiovascular disease (CVD) among cancer survivors, were selected. Pooled hazard ratios (pHRs) and 95% confidence intervals (CIs) were estimated using random effects models. Tests for heterogeneity and publication bias were conducted.Twenty-two studies involving 209,659 survivors with an average follow-up duration ranging from 4.1 to 29.1 years were included. pHRs(95%CI) comparing cancer survivors with the healthiest lifestyles versus those with the least healthy lifestyles were 0.57 (0.51-0.65) for all-cause mortality, 0.70 (0.61-0.80) for cancer-specific mortality, and 0.53 (0.46-0.63) for CVD incidence. These associations were largely consistent across subgroup analyses. Colorectal cancer survivors with the healthiest lifestyle experienced 37% lower all-cause mortality and 25% lower cancer-specific mortality, while breast cancer survivors had a 45% reduction in all-cause mortality. Although studies were limited, significant associations for all-cause mortality were observed among lung, liver, nasopharyngeal, gastric, kidney, gynecologic cancer survivors. However, no significant relationship between healthy lifestyles and CVD-specific mortality was detected.Having an overall healthy lifestyle is associated with lower CVD incidence and better survival among cancer survivors. The long-term management of cancer survivors should consider encouragement for a modification of multiple lifestyles.
000294812 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000294812 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000294812 650_7 $$2Other$$aCancer survivor
000294812 650_7 $$2Other$$aCardiovascular disease
000294812 650_7 $$2Other$$aLifestyle
000294812 650_7 $$2Other$$aMeta-analysis
000294812 650_7 $$2Other$$aMortality
000294812 650_7 $$2Other$$aSystematic review
000294812 650_2 $$2MeSH$$aHumans
000294812 650_2 $$2MeSH$$aCancer Survivors: statistics & numerical data
000294812 650_2 $$2MeSH$$aCardiovascular Diseases: mortality
000294812 650_2 $$2MeSH$$aCardiovascular Diseases: etiology
000294812 650_2 $$2MeSH$$aCardiovascular Diseases: epidemiology
000294812 650_2 $$2MeSH$$aLife Style
000294812 650_2 $$2MeSH$$aNeoplasms: mortality
000294812 650_2 $$2MeSH$$aCohort Studies
000294812 650_2 $$2MeSH$$aRisk Factors
000294812 7001_ $$0P:(DE-He78)f303fd16782cb36dee5eeffb83d0efca$$aLian, Zhiwei$$b1$$udkfz
000294812 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b2$$udkfz
000294812 7001_ $$0P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aThong, Melissa$$b3$$eLast author$$udkfz
000294812 773__ $$0PERI:(DE-600)1463166-0$$a10.1007/s00520-024-09049-2$$gVol. 32, no. 12, p. 846$$n12$$p846$$tSupportive care in cancer$$v32$$x0941-4355$$y2024
000294812 909CO $$ooai:inrepo02.dkfz.de:294812$$pVDB
000294812 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000294812 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f303fd16782cb36dee5eeffb83d0efca$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000294812 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000294812 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000294812 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000294812 9141_ $$y2024
000294812 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000294812 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000294812 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSUPPORT CARE CANCER : 2022$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000294812 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000294812 9202_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000294812 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000294812 9200_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000294812 980__ $$ajournal
000294812 980__ $$aVDB
000294812 980__ $$aI:(DE-He78)C071-20160331
000294812 980__ $$aUNRESTRICTED